Overview:
Orabloc is a powerful and effective dental anesthetic combining Articaine Hydrochloride 4% with Epinephrine 1:100,000. Designed to provide quick onset and profound anesthesia, Orabloc is an excellent choice for a variety of dental procedures. It ensures patient comfort and reliable performance, making it a trusted product among dental professionals.
Specifications:
-
Active Ingredients: Articaine Hydrochloride 4%, Epinephrine 1:100,000
-
Form: Injectable solution
-
Packaging: 50 cartridges per box.
-
Volume per Cartridge: 1.7 mL
-
Canadage: Local dental anesthesia for procedures requiring profound anesthesia
-
Onset Time: Rapid onset, typically within 1 to 3 minutes
-
Duration: Provides effective anesthesia for a duration of 1 to 2 hours for infiltration and up to 4 hours for nerve block.
-
Compatibility: Can be used with standard dental syringes
- Manufacturer Part No. ORABLOC 1:1
Features and Benefits:
-
Fast Onset: Provides rapid anesthesia onset, allowing dental procedures to begin quickly.
-
Effective Duration: Ensures prolonged anesthesia, enhancing patient comfort during lengthy dental procedures.
-
High Potency: Articaine's unique formulation allows for deeper penetration and superior efficacy.
-
Contains Epinephrine: The addition of epinephrine helps reduce bleeding in the surgical area and prolongs the anesthetic effect.
-
Safe and Reliable: Manufactured under stringent quality controls to ensure safety and consistency.
-
Convenient Packaging: It comes in a box of 50 cartridges, providing ample supply for dental practices.
The Orabloc Anesthetic with Articaine Hydrochloride 4% and Epinephrine 1:100,000 is ideal for dental professionals seeking a reliable, effective local anesthetic for a wide range of dental procedures.
Manufacturer:
Pierrel Pharma SRL, a subsidiary of Pierrel S.p.A., specializes in the development, production, registration, marketing, and commercialization of dental anesthetics and medical devices for oral health. Founded in 1948 and based in Capua, Italy, Pierrel is a prominent player in the pharmaceutical market with over 70 years of experience.
Pierrel Pharma is recognized for its significant contributions to dental anesthesia, including products like Ubistesin™, Xylestesin™, Mepivastesin™, and Orabloc™, which are widely used globally. The company has received authorizations from major regulatory bodies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), enabling it to produce and market injectable drugs and dental anesthetics internationally.
The company's production facility is equipped for aseptic production, ensuring high-quality and safe products. Pierrel Pharma also engages in contract manufacturing, producing dental anesthetics for various international brands.
